Follow
Salvatore Ferla
Salvatore Ferla
Verified email at swansea.ac.uk
Title
Cited by
Cited by
Year
Polyfluorinated groups in medicinal chemistry
M Bassetto, S Ferla, F Pertusati
Future Medicinal Chemistry 7 (4), 527-546, 2015
1092015
A novel interaction between dengue virus nonstructural protein 1 and the NS4A-2K-4B precursor is required for viral RNA replication but not for formation of the membranous …
A Płaszczyca, P Scaturro, CJ Neufeldt, M Cortese, B Cerikan, S Ferla, ...
PLoS Pathogens 15 (5), e1007736, 2019
812019
Quercetin derivatives as novel antihypertensive agents: Synthesis and physiological characterization
F Grande, OI Parisi, RA Mordocco, C Rocca, F Puoci, L Scrivano, ...
European Journal of Pharmaceutical Sciences 82, 161-170, 2016
732016
Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer
M Bassetto, S Ferla, F Pertusati, S Kandil, AD Westwell, A Brancale, ...
European Journal of Medicinal Chemistry 118, 230-243, 2016
702016
Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis
SN Lauder, K Allen-Redpath, DA Slatter, M Aldrovandi, A O’Connor, ...
Science signaling 10 (507), eaan2787, 2017
492017
Discovery of novel multi-target indole-based derivatives as potent and selective inhibitors of chikungunya virus replication
M Scuotto, R Abdelnabi, S Collarile, C Schiraldi, L Delang, A Massa, ...
Bioorganic & medicinal chemistry 25 (1), 327-337, 2017
462017
Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni
G Padalino, S Ferla, A Brancale, IW Chalmers, KF Hoffmann
International Journal for Parasitology: Drugs and Drug Resistance 8 (3), 559-570, 2018
422018
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and …
R Romagnoli, F Prencipe, P Oliva, S Baraldi, PG Baraldi, ...
Journal of Medicinal Chemistry 62 (3), 1274-1290, 2019
392019
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole
R Romagnoli, PG Baraldi, F Prencipe, P Oliva, S Baraldi, MA Tabrizi, ...
Scientific reports 6 (1), 26602, 2016
372016
Suramin inhibits chikungunya virus replication by interacting with virions and blocking the early steps of infection
IC Albulescu, L White-Scholten, A Tas, TE Hoornweg, S Ferla, ...
Viruses 12 (3), 314, 2020
302020
The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets
KCL Whatley, G Padalino, H Whiteland, KK Geyer, BJ Hulme, ...
PLoS Neglected Tropical Diseases 13 (11), e0007693, 2019
302019
In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase
S Ferla, NE Netzler, S Ferla, S Veronese, DE Tuipulotu, S Guccione, ...
Scientific reports 8 (1), 4129, 2018
302018
Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP)
L Bauer, S Ferla, SA Head, S Bhat, KK Pasunooti, WQ Shi, L Albulescu, ...
Antiviral Research 156, 55-63, 2018
272018
Therapeutically targeting guanylate cyclase‐C: computational modeling of plecanatide, a uroguanylin analog
A Brancale, K Shailubhai, S Ferla, A Ricci, M Bassetto, GS Jacob
Pharmacology Research & Perspectives 5 (2), e00295, 2017
272017
Successful subthalamic stimulation in genetic Parkinson’s disease caused by duplication of the α-synuclein gene
A Antonini, M Pilleri, A Padoan, A Landi, S Ferla, R Biundo, D D’Avella
Journal of neurology 259, 165-167, 2012
272012
Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo [b] furan derivatives as highly potent tubulin polymerization inhibitors
P Oliva, R Romagnoli, S Manfredini, A Brancale, S Ferla, E Hamel, ...
European Journal of Medicinal Chemistry 200, 112448, 2020
262020
Broad-spectrum non-nucleoside inhibitors for caliciviruses
NE Netzler, DE Tuipulotu, AA Eltahla, JH Lun, S Ferla, A Brancale, ...
Antiviral research 146, 65-75, 2017
262017
Targeting the complement serine protease MASP-2 as a therapeutic strategy for coronavirus infections
BM Flude, G Nannetti, P Mitchell, N Compton, C Richards, M Heurich, ...
Viruses 13 (2), 312, 2021
242021
Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C
L Bauer, R Manganaro, B Zonsics, DL Hurdiss, M Zwaagstra, T Donselaar, ...
PLoS Biology 18 (11), e3000904, 2020
242020
Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitors
R Manganaro, B Zonsics, L Bauer, ML Lopez, T Donselaar, M Zwaagstra, ...
Antiviral Research 178, 104781, 2020
242020
The system can't perform the operation now. Try again later.
Articles 1–20